Results 161 to 170 of about 18,647 (241)

Rituximab in Mucous Membrane Pemphigoid: Current Evidence and Clinical Perspectives. [PDF]

open access: yesHealthcare (Basel)
Popa LG   +6 more
europepmc   +1 more source

Combination biologic therapy in bullous pemphigoid: two case reports and a focused review. [PDF]

open access: yesFront Immunol
Kyriakou A   +9 more
europepmc   +1 more source

A Multicenter Analysis of Patients with Bullous Pemphigoid: Clinical Characteristics and Insights into Drug-Associated Disease. [PDF]

open access: yesInt J Mol Sci
Małolepsza A   +12 more
europepmc   +1 more source

FcεRII (CD23) in dermatological disorders: structure, function, and clinical implications. [PDF]

open access: yesFront Allergy
Zdanowska N   +4 more
europepmc   +1 more source

Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients. [PDF]

open access: yesActa Derm Venereol
Pira A   +28 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy